Profile picture

Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)
Membership: HFA Member
Follow
Logo ESC

Contributor content

The role of albuminuria in acute heart failure: from admission to early post-discharge outcomes
Presentation
The role of albuminuria in acute heart failure: from admission to early post-discharge outcomes
Read more
Prognosis value of early albuminuria trajectory after acute heart failure
Presentation
Prognosis value of early albuminuria trajectory after acute heart failure
Read more
Tracking albuminuria in acute heart failure: a clue to long-term prognosis
Presentation
Tracking albuminuria in acute heart failure: a clue to long-term prognosis
Read more
Donation after circulatory death in a European ultraperipheral and multi-insular region.
Presentation
Donation after circulatory death in a European ultraperipheral and multi-insular region.
Read more
Use of vericiguat: real-world outcomes and insights from the VERITA registry.
Presentation
Use of vericiguat: real-world outcomes and insights from the VERITA registry.
Read more
Pre-transplant clinical and post-transplant outcomes of patients with a novel mutation in the emerin gene
Presentation
Pre-transplant clinical and post-transplant outcomes of patients with a novel mutation in the emerin gene
Read more
Five-year evaluation of the first heart transplant program in a European ultraperipheral region: characteristics, outcomes and implications
Presentation
Five-year evaluation of the first heart transplant program in a European ultraperipheral region: characteristics, outcomes and implications
Read more
Albuminuria and acute heart failure. Prognostic implications and short-term mortality.
Presentation
Albuminuria and acute heart failure. Prognostic implications and short-term mortality.
Read more
Prognosis changes in patients with transthyretin cardiac amyloidosis after attr-act study.
Presentation
Prognosis changes in patients with transthyretin cardiac amyloidosis after attr-act study.
Read more
Prognosis value of cardiac biomarkers in transthyretin deposition cardiac amyloidosis in real life
Presentation
Prognosis value of cardiac biomarkers in transthyretin deposition cardiac amyloidosis in real life
Read more

ESC 365 is supported by

novartis Explore sponsored resources